Article Details

Race Oncology (ASX:RAC) appoints Parexel for AML clinical trial

Retrieved on: 2021-06-02 01:29:55

Tags for this article:

Click the tags to see associated articles and topics

Race Oncology (ASX:RAC) appoints Parexel for AML clinical trial. View article details on hiswai:

Excerpt

Subscribe · Race Oncology (RAC) has chosen contract research organisation Parexel International to support its Acute Myeloid Leukemia (AML) clinical ...

Article found on: themarketherald.com.au

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up